rs1554121443
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_006772.3(SYNGAP1):c.1630C>T(p.Arg544*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006772.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYNGAP1 | NM_006772.3 | c.1630C>T | p.Arg544* | stop_gained | Exon 10 of 19 | ENST00000646630.1 | NP_006763.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYNGAP1 | ENST00000646630.1 | c.1630C>T | p.Arg544* | stop_gained | Exon 10 of 19 | NM_006772.3 | ENSP00000496007.1 | |||
SYNGAP1 | ENST00000644458.1 | c.1630C>T | p.Arg544* | stop_gained | Exon 10 of 19 | ENSP00000495541.1 | ||||
SYNGAP1 | ENST00000449372.7 | c.1630C>T | p.Arg544* | stop_gained | Exon 10 of 18 | 5 | ENSP00000416519.4 | |||
SYNGAP1 | ENST00000418600.7 | c.1630C>T | p.Arg544* | stop_gained | Exon 10 of 19 | 5 | ENSP00000403636.3 | |||
SYNGAP1 | ENST00000645250.1 | c.1453C>T | p.Arg485* | stop_gained | Exon 8 of 17 | ENSP00000494861.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 5 Pathogenic:4
This nonsense variant is categorized as deleterious according to ACMG guidelines (PMID:18414213) and was found once in our laboratory de novo in an 11-year-old female with Leigh disease, intellectual disability, short stature, microcephaly, failure to thrive, PDA, brachydactyly, pes planus, congenital hypothyroidism. Patient also carried compound heterozygous pathogenic variants in MTFMT. -
A mosaic c.1630C>T (p.R544X) pathogenic variant in the SYNGAP1 gene was detected in this individual (33 mutant and 256 reference reads) and was confirmed by Sanger sequencing. This variant has been previously reported as de novo in a patient with intellectual disability and developmental delay (PMID: 26989088) and is predicted to result in a premature stop codon. -
This nonsense variant found in exon 10 of 19 is predicted to result in loss of normal protein function. This variant has been previously reported as a de novo change in a patient with global developmental delay and epilepsy (PMID: 26989088). It is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. Based on the available evidence, the c.1630C>T (p.Arg544Ter) variant is classified as pathogenic. -
This sequence change creates a premature translational stop signal (p.Arg544*) in the SYNGAP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SYNGAP1 are known to be pathogenic (PMID: 23161826, 23708187, 26989088). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with infantile epileptic encephalopathy (PMID: 26989088). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 522845). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31349857, 25326635, 26989088) -
- -
Inborn genetic diseases Pathogenic:1
The c.1630C>T (p.R544*) alteration, located in exon 10 (coding exon 10) of the SYNGAP1 gene, consists of a C to T substitution at nucleotide position 1630. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 544. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been reported to occur de novo in a patient with severe intellectual disability, truncal hypotonia, swallowing difficulties, epilepsy, and very poor social interactions (Mignot, 2016). In addition, this alteration has also been identified in a patient with generalized epilepsy (Hoelz, 2020) and in a mosaic patient with a neurodevelopmental phenotype (Cao, 2019). Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at